Jiangxi Fushine Pharmaceutical Co Ltd Net Asset Momentum
Jiangxi Fushine Pharmaceutical Co Ltd net asset momentum. Jiangxi Fushine Pharmaceutical Co Ltd (300497) recorded a net asset momentum of 1.1% as of December 2025, with net assets of CN¥2.20 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 300497 book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Net asset momentum of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. This chart tracks Jiangxi Fushine Pharmaceutical Co Ltd's year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is +1.1%, with net assets of CN¥2.20 Billion CNY as of December 2025. Check Jiangxi Fushine Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Jiangxi Fushine Pharmaceutical Co Ltd Net Asset Momentum by Year (2011–2025)
Jiangxi Fushine Pharmaceutical Co Ltd net asset momentum by year from 2011 to 2025. The table below shows the complete annual net asset history for Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 300497 stock market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥2.20 Billion | CN¥4.40 Billion | CN¥2.20 Billion | ▲ +1.1% |
| 2024 | CN¥2.18 Billion | CN¥4.54 Billion | CN¥2.36 Billion | ▼ -11.9% |
| 2023 | CN¥2.47 Billion | CN¥4.82 Billion | CN¥2.35 Billion | ▼ -8.1% |
| 2022 | CN¥2.69 Billion | CN¥5.06 Billion | CN¥2.37 Billion | ▼ -7.6% |
| 2021 | CN¥2.91 Billion | CN¥4.68 Billion | CN¥1.77 Billion | ▼ -4.5% |
| 2020 | CN¥3.05 Billion | CN¥4.05 Billion | CN¥997.93 Million | ▲ +99.5% |
| 2019 | CN¥1.53 Billion | CN¥2.60 Billion | CN¥1.07 Billion | ▲ +33.2% |
| 2018 | CN¥1.15 Billion | CN¥2.20 Billion | CN¥1.05 Billion | ▲ +18.6% |
| 2017 | CN¥966.71 Million | CN¥1.79 Billion | CN¥822.70 Million | ▲ +23.3% |
| 2016 | CN¥784.17 Million | CN¥1.40 Billion | CN¥614.20 Million | ▲ +31.5% |
| 2015 | CN¥596.21 Million | CN¥1.01 Billion | CN¥413.44 Million | ▲ +110.5% |
| 2014 | CN¥283.26 Million | CN¥632.35 Million | CN¥349.09 Million | ▲ +23.3% |
| 2013 | CN¥229.76 Million | CN¥541.31 Million | CN¥311.55 Million | ▲ +24.5% |
| 2012 | CN¥184.60 Million | CN¥476.31 Million | CN¥291.70 Million | ▲ +53.2% |
| 2011 | CN¥120.52 Million | CN¥352.57 Million | CN¥232.04 Million | — |